Seeking Alpha

Repligen (RGEN -0.3%) shareholder Ronald L. Chez says that after speaking to Board Chairperson...

Repligen (RGEN -0.3%) shareholder Ronald L. Chez says that after speaking to Board Chairperson Karen Dawes, he plans to call as special meeting to discuss reducing the number of shares outstanding in the company and other strategic alternatives for the company on the back of recent developments in its new drug application for RG1068.
Comments (1)
  • francis williams
    , contributor
    Comments (24) | Send Message
     
    Just a stock holder, nothing else.
    Believe in this company. At 4+, it's a steal. It will take us from, off course, to main street within a year.
    30 Apr 2012, 05:09 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|